Healthcare >> Analyst Interviews >> May 26, 2003

Investing In Life Science-based Companies: Jonathan Fleming – Oxford Bioscience Partners

JONATHAN J. FLEMING has been in the investment business for over 17 years, starting and financing growth companies in the United States, Europe and Israel. Prior to joining OBP in 1996, he was a Founding General Partner of MVP Ventures in Boston, Massachusetts. He began his investment career with TVM Techno Venture Management in Munich, Germany. Mr. Fleming has also co- founded Medica Venture Partners, a venture capital investment firm specializing in early stage healthcare and biotechnology companies in Israel. Mr. Fleming holds a Master's degree in Public Administration from Princeton University and a Bachelor of Arts degree from the University of California, Berkeley. Mr. Fleming is a co-Founder and is Chairman of the Board of Memory Pharmaceuticals, Hypnion, Inc. and Dynogen Corporation. Profile
TWST: Would you give us a brief overview of Oxford Bioscience

Partners?

Mr. Fleming: Oxford Bioscience Partners is a venture capital

firm, focused exclusively on life science based companies.